Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback from the Covid straitjacket that so many of these companies got caught up in. The pandemic obscured so much of the growth as Abbott Labs , … Read more
We’re making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to join Jim Cramer’s Charitable Trust. We’re highlighting the four most interesting investment opportunities we found out of the handful of company CEOs Jim interviewed at this week’s JPMorgan … Read more
CNBC’s Jim Cramer applauded Monday’s market gains for Big Tech, which had seen a sell-off in the early days of the new year as Wall Street shifted its focus to a number of other sectors. He advised investors to keep a diverse portfolio, buying shares in health-care companies and paying attention to industry leaders who … Read more
Walgreens CEO Tim Wentworth told CNBC’s Jim Cramer that the company is using its stores and brand to bolster its developing health-care business. Walgreens has made significant investments over the past few years to expand beyond a drugstore chain into a large health-care company. Wentworth acknowledged that the company has been closing stores to make … Read more
CNBC’s Jim Cramer on Friday told investors what to watch for on Wall Street next week, highlighting JPMorgan‘s market-moving health-care conference in San Francisco. Taking place from Monday to Thursday, the conference is one of the year’s largest gatherings of major industry CEOs where they reveal earnings guidance and updates on clinical trial research. “The … Read more
CNBC’s Jim Cramer on Thursday gave his take on the worst performers in the Nasdaq-100 in 2023. Cramer compared each company’s closing price in 2022 to the end of 2023, noting the biggest losers. The list included healthcare companies as well as several utilities outfits. “You’ve heard of the Dogs of the Dow? Well, now … Read more
Shares of Walgreens fell more than 11% on Thursday after the company reported fiscal first-quarter adjusted earnings and revenue that topped expectations, but cut its quarterly dividend nearly in half. The retail pharmacy giant slashed its dividend to 25 cents per share from 48 cents per share to “strengthen [its] long-term balance sheet and cash position,” … Read more
CNBC’s Jim Cramer on Tuesday broke down the five best and worst performers on the Dow Jones Industrial Average during 2023. Cramer compared each Dow company’s closing price in 2022 to the end of 2023, noting the most significant winners and losers. Many tech-related stocks saw significant full-year gains, while some stocks with the greatest … Read more
